Credit Suisse Can Achieve 15% ROE Target, CEO Says

Oct. 25 (Bloomberg) -- Credit Suisse Group AG Chief Executive Officer Brady Dougan talks about third-quarter profit, return on equity targets and capital levels. He speaks in Zurich with Bloomberg Television's Caroline Hyde. (Source: Bloomberg)

Merck KgaA, Pfizer Cancer Drug to Cost $13,000 a Month
11:06 - Pfizer and Merck KGaA’s cancer immunotherapy won approval from U.S. regulators for patients with a rare form of skin cancer, and the companies plan to sell the drug for $13,000 a month. Merck KgaA CEO Stegfan Oschmann speaks on "Bloomberg Daybreak Europe." (Source: Bloomberg)
  • Aviva's Diebel Sees No Macro Impact From Healthcare Bill
  • Italy Junior Minister Sees Brexit as EU Opportunity
  • French Presidential Race Takes an Inflammatory Turn